Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Readthrough AChE splice variant may be linked to Abeta pathology in AD

Jan. 16, 2008

Novel psychopharmacologic drugs described

Jan. 15, 2008

Diamyd submits IND for phase I novel chronic pain therapy trial

Jan. 15, 2008

Hemispherx submits responses to FDA questions on NDA for Ampligen for CFS

Jan. 15, 2008

Cadence reports topline results from the 301 and 302 phase III clinical trials of Acetavance

Jan. 15, 2008

Intranasal versus i.v. orexin-A in memory enhancement of sleep-deprived monkeys

Jan. 15, 2008

Potent analgesic activity of ABT-102 in preclinical studies

Jan. 15, 2008

Recent patents describe novel agents for neurological disorders

Jan. 14, 2008

FDA accepts for filing BioDelivery Sciences' NDA for BEMA Fentanyl for cancer pain

Jan. 14, 2008

Amarin to initiate phase IIa trial of AMR-101 for age-associated memory impairment

Jan. 14, 2008

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...